Gershoni-Baruch Ruth, Broza Yiftah, Brik Riva
Department of Human Genetics, Rambam Medical Center, and the Bruce Rappoport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
J Pediatr. 2003 Nov;143(5):658-61. doi: 10.1067/S0022-3476(03)00502-X.
Based on the fact that Henoch-Schönlein purpura (HSP) occurs in approximately 5% of persons with familial Mediterranean fever (FMF), we assessed the prevalence and significance of FMF gene mutations in children with one or more episodes of HSP.
Thirty-four boys and 18 girls treated for HSP at Rambam Medical Center were interviewed and asked to donate blood. Mean age at disease onset was 6.7+/-2. 4 years, and mean follow-up was 3.8+/-1.3 years. Six predominant mutations (M694V, M680I, M694I, V726A, K695R, E148Q) in the MEFV gene were studied.
Nine heterozygotes, three homozygotes and two compound heterozygotes, were identified. Altogether, five persons (10%) carried two mutated MEFV alleles, a number significantly exceeding that determined for the general Israeli population (1%-2%). Of these, three displayed genotypes associated with a mild form of disease (M694V/E148Q and V726A/V726A), and two had genotypes normally observed in disease-free persons (E148Q/K695R and E148Q/E148Q).
Occult FMF cases much more numerous than expected were identified among children presenting with HSP. Such children should be closely monitored for renal complications, and treatment with colchicine should be considered.
鉴于约5%的家族性地中海热(FMF)患者会发生过敏性紫癜(HSP),我们评估了有一次或多次HSP发作的儿童中FMF基因突变的患病率及意义。
对在兰巴姆医疗中心接受HSP治疗的34名男孩和18名女孩进行访谈并采集血样。疾病发作时的平均年龄为6.7±2.4岁,平均随访时间为3.8±1.3年。研究了MEFV基因中的6种主要突变(M694V、M680I、M694I、V726A、K695R、E148Q)。
鉴定出9名杂合子、3名纯合子和2名复合杂合子。共有5人(10%)携带两个突变的MEFV等位基因,这一数字显著超过以色列普通人群的比例(1%-2%)。其中,3人表现出与轻度疾病相关的基因型(M694V/E148Q和V726A/V726A),2人具有在无病个体中通常观察到的基因型(E148Q/K695R和E148Q/E148Q)。
在患有HSP的儿童中发现的隐匿性FMF病例比预期的要多得多。应对此类儿童密切监测肾脏并发症,并考虑使用秋水仙碱进行治疗。